Chapple, Christopher R <br/><br/>
Monotherapy with α-blocker or phosphodiesterase 5 inhibitor for lower urinary tract symptoms?  [electronic resource] 

 -  European urology  May 2012 
 - 926-7 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2012.02.040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-1 Receptor Antagonists--therapeutic use<br/>Carbolines--therapeutic use<br/>Humans<br/>Lower Urinary Tract Symptoms--drug therapy<br/>Male<br/>Prostatic Hyperplasia--drug therapy<br/>Sulfonamides--therapeutic use<br/>Tadalafil<br/>Tamsulosin<br/>Vasodilator Agents--therapeutic use